Literature DB >> 870512

The effect of sodium restriction and prostaglandin inhibition on the renin-angiotensin system in man.

P Speckart, P Zia, R Zipser, R Horton.   

Abstract

To investigate the possible interrelationship between the renin-angiotensin and prostaglandin systems, two groups of normal men were evaluated under conditions of varied sodium intake and after indomethacin, an inhibitor of prostaglandin synthesis. Eight subjects were placed on a 200 mEq Na diet and given 45 min infusions of prostaglandin A1 (PGA1) at 0.075 microng/kg/min and angiotensin II at 10 ng/kg/min on separate mornings. PGA1 produced a significant rise in both plasma renin activity (PRA) and aldosterone. Angiotensin II caused a similar rise in aldosterone. The patients were then placed on a 10-20 mEq Na diet and the infusions repeated. PGA1 again induced a further increase in both PRA and aldosterone. Angiotensin II produced the expected increase in aldosterone while PRA decreased. Body weight and 24 h sodium excretion were not different from control days on either diet. When indomethacin was administered to patients on the low sodium diet, PRA fell significantly and there was an increased pressor responsiveness to angiotensin. In a separate group of 4 patients on a low salt intake, basal PRA fell significantly during a 4 day period of indomethacin administration and returned to control values within 48 h after discontinuing the drug. These studies suggest that PGA1 infusions stimulate renin release independently of sodium balance. Inhibition of prostaglandin synthesis lowers PRA and increases pressor responsiveness to angiotensin. The data provide further evidence that vasodepressor prostaglandins may play a role in renin release and blood pressure homeostasis.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 870512     DOI: 10.1210/jcem-44-5-832

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

1.  Non-steroidal anti-inflammatory drugs and the kidney.

Authors:  M L Orme
Journal:  Br Med J (Clin Res Ed)       Date:  1986-06-21

2.  Disposition of azapropazone in chronic renal and hepatic failure.

Authors:  K H Breuing; H J Gilfrich; T Meinertz; U W Wiegand; E Jähnchen
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

Review 3.  Prostaglandins, thromboxanes and leukotrienes in clinical medicine.

Authors:  R D Zipser; G Laffi
Journal:  West J Med       Date:  1985-10

4.  Mechanism of decreased vascular reactivity to angiotensin II in conscious, potassium-deficient rats.

Authors:  M S Paller; J G Douglas; S L Linas
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

5.  The pressor actions of noradrenaline and angiotension II in chronic autonomic failure treated with indomethacin.

Authors:  I B Davies; R Bannister; C Hensby; P S Sever
Journal:  Br J Clin Pharmacol       Date:  1980-09       Impact factor: 4.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.